Notice of Results

RNS Number : 0237D

e-Therapeutics plc

10 May 2012

 

e-Therapeutics plc

Notice of Preliminary Results

e-Therapeutics plc (AIM: ETX), the biotechnology company with a proprietary platform in network pharmacology, will be announcing its final results for the 12 month period ending 31^st January 2012 on Tuesday 22^nd May 2012.

Professor Malcolm Young, CEO, Daniel Elger, CFO, and Stephen Self, Development Director, will be hosting an analyst presentation in London on the morning of the results. Please contact College Hill if you are interested in attending the meeting.

-Ends-

For more information, please contact:

e-Therapeutics plc

Malcolm Young / Daniel Elger

Tel: [phone]

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Andrew Burnett / Fred Walsh

Tel: [phone]

www.panmure.com

College Hill

Melanie Toyne Sewell / Jayne Crook

Tel: [phone]

Email: [e-mail]

 

END

 

 

NORQKLFBLEFZBBX